Intelligent Bio Solutions Inc. SEC filings INBS

Intelligent Bio Solutions Inc. has 467 filings in SEC EDGAR's recent list, going back to Dec 29, 2017. Its latest annual report, Form ARS, was filed on Nov 2, 2026 for the period ended Jun 30, 2026. The latest quarterly report (Form 10-Q) was filed on May 13, 2026, covering the quarter ended Mar 31, 2026. The most recent current report (Form 8-K) was filed on Oct 13, 2026 (bylaw or fiscal year change, regulation fd disclosure). The company's fiscal year ends on June 30.

Intelligent Bio Solutions Inc. SEC filings
Form Description Filed Period
10-Q Quarterly report May 13, 2026 Mar 31, 2026
10-Q Quarterly report Feb 12, 2026 Dec 31, 2025
10-Q Quarterly report Nov 12, 2025 Sep 30, 2025
10-Q Quarterly report May 13, 2025 Mar 31, 2025
10-Q Quarterly report Feb 13, 2025 Dec 31, 2024
10-Q Quarterly report Nov 7, 2024 Sep 30, 2024
10-Q Quarterly report May 8, 2024 Mar 31, 2024
10-Q Quarterly report Feb 9, 2024 Dec 31, 2023
10-Q Quarterly report Nov 8, 2023 Sep 30, 2023
10-Q Quarterly report May 11, 2023 Mar 31, 2023
10-Q Quarterly report Feb 14, 2023 Dec 31, 2022
10-Q Quarterly report Nov 14, 2022 Sep 30, 2022
10-Q Quarterly report May 16, 2022 Mar 31, 2022
10-Q Quarterly report Feb 11, 2022 Dec 31, 2021
10-Q Quarterly report Nov 12, 2021 Sep 30, 2021
10-Q Quarterly report May 13, 2021 Mar 31, 2021
10-Q Quarterly report Feb 12, 2021 Dec 31, 2020

Showing 17 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Surgical & Medical Instruments & Apparatus (SIC 3841)
Listed as
INBS (Nasdaq)
Fiscal year ends
June 30
Incorporated in
DE
Headquarters
New York, NY
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1725430
Former names
GBS Inc. (until Oct 18, 2022); Glucose Biosensor Systems (Greater China) Holdings, Inc. (until Sep 19, 2019)

Other Surgical & Medical Instruments & Apparatus companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.